Olaf Heinrich

Redcare Pharmacy reported Q1 2026 German prescription revenue of €168 million, a 55% YoY increase and beating the €162 million consensus estimate. Group revenue rose 18.3% to €848 million, surpassing

Redcare Pharmacy NV reported Q1 2026 group revenue of €848 million, up 18.3% YoY from €717 million. German Rx revenue surged 55% to €168 million, driving DACH segment revenue to €692 million, up 18.9%